European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes - Page 1

European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes

European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes

None

videos

views

Last updated

21:46

Current Understanding of a Genetic/Epigenetic Basis of Classic MPNs

HMP Education

24:37

Current Understanding of a Genetic/Epigenetic Basis of MDS

HMP Education

22:59

5q Minus Syndrome: What we know (and what we don't know yet)

HMP Education

23:39

Why MPN transforms to AML

HMP Education

17:53

Biology of AML Developing from MDS vs. de Novo AML, and New Targets for Therapy

HMP Education

18:53

Mutations in MF: Which to test for, when and why

HMP Education

16:29

Inadequate or Loss of Response to Ruxolitinib, and Combination Strategies

HMP Education

20:42

Beyond JAK2 Inhibitors: New targets and new agents

HMP Education

20:12

MPN Transformation to MDS and AML: Risk factors, therapy and outcomes

HMP Education

16:10

Stem Cell Transplant for Myelofibrosis in the JAK2 Inhibitor Era

HMP Education

17:47

Current Status of Risk Stratification of Patients with MDS

HMP Education

26:18

When and How to Use Iron Chelation Therapy in MDS

HMP Education

19:18

Understanding Efficacy of Azacitidine in Different MDS Subgroups

HMP Education

21:59

Diagnosis and Therapy of CMML in 2015

HMP Education

15:59

Which Cytoreductive Therapy Before Transplant for MDS?

HMP Education

19:23

Role of Microenvironment in MPN

HMP Education

14:40

Role of STATs in MPNs

HMP Education

26:50

“Masked” Polycythemia vera: Time to change WHO diagnostic criteria

HMP Education

21:43

Hydroxyurea Intolerance/Resistance in Polycythemia vera

HMP Education

18:09

Diagnosis, Prognosis, and Therapy of True ET vs. Prefibrotic MF

HMP Education